Diabetes drug side effect reports triple
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20070713/ap_on_he_me/diabetes_drug_risks"><img src="http://d.yimg.com/us.yimg.com/p/ap/20070713/capt.089683c7c6354f3fb5351726dc977e63.diabetes_drug_risks_ny122.jpg?x=130&y=98&sig=fZr3GvHBQZM13qtQvYSytA--" align="left" height="98" width="130" alt="Moncef Slaoui,, chairman of Research and Development at GalaxoSmithKline testifies on Capitol Hill in Washington, in this Wednesday, June 6, 2007 file photo, before the House Oversight and Government Reform committee hearing on the diabetes drug Avandia. In the month after a surprising analysis revealed possible heart risks from the blockbuster diabetes drug Avandia, reports of side effects to federal regulators tripled. (AP Photo/Susan Walsh)" border="0" /></a>AP - In the month after a surprising analysis revealed possible heart risks from the blockbuster diabetes drug Avandia, reports of side effects to federal regulators tripled.</p><br clear="all"/>

Read more...